December 2014 Life Science Industry Research Reports

Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) […]

Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) […]

Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) […]

Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) […]

Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) […]

Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) […]

GlobalData has released its pharma report, “PharmaPoint: Irritable Bowel Syndrome Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Irritable Bowel Syndrome Market. The report identifies […]

Vitamin industry hot topics in 2014: On 19 March, 2014, BASF released a statement that its citral production line in Germany plant suffered a fire and had to close down. BASF’s total citral capacity accounts for more than 60% of […]

BMI View: In the face of increasing product launches within highly-competitive therapeutic areas such as diabetes care in the US, payers are becoming ever more confident in leveraging their purchasing power over pharmaceutical companies. With few differentiating factors between competing […]

BMI View: The deterioration of the Spanish economy and the government’s implementation of increasingly aggressive fiscal austerity policies that focus on cost containment in the healthcare sector seriously hinder the country’s attractiveness to drugmakers. Despite calls made by companies for […]